1. Home
  2. BRID vs SKYE Comparison

BRID vs SKYE Comparison

Compare BRID & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRID
  • SKYE
  • Stock Information
  • Founded
  • BRID 1932
  • SKYE 2012
  • Country
  • BRID United States
  • SKYE United States
  • Employees
  • BRID N/A
  • SKYE N/A
  • Industry
  • BRID Specialty Foods
  • SKYE Biotechnology: Pharmaceutical Preparations
  • Sector
  • BRID Consumer Staples
  • SKYE Health Care
  • Exchange
  • BRID Nasdaq
  • SKYE Nasdaq
  • Market Cap
  • BRID 93.2M
  • SKYE 80.7M
  • IPO Year
  • BRID N/A
  • SKYE N/A
  • Fundamental
  • Price
  • BRID $10.29
  • SKYE $3.14
  • Analyst Decision
  • BRID
  • SKYE Buy
  • Analyst Count
  • BRID 0
  • SKYE 6
  • Target Price
  • BRID N/A
  • SKYE $18.67
  • AVG Volume (30 Days)
  • BRID 1.9K
  • SKYE 178.7K
  • Earning Date
  • BRID 03-07-2025
  • SKYE 02-18-2025
  • Dividend Yield
  • BRID N/A
  • SKYE N/A
  • EPS Growth
  • BRID N/A
  • SKYE N/A
  • EPS
  • BRID N/A
  • SKYE N/A
  • Revenue
  • BRID $223,645,000.00
  • SKYE N/A
  • Revenue This Year
  • BRID N/A
  • SKYE N/A
  • Revenue Next Year
  • BRID N/A
  • SKYE N/A
  • P/E Ratio
  • BRID N/A
  • SKYE N/A
  • Revenue Growth
  • BRID N/A
  • SKYE N/A
  • 52 Week Low
  • BRID $7.77
  • SKYE $2.31
  • 52 Week High
  • BRID $14.69
  • SKYE $19.41
  • Technical
  • Relative Strength Index (RSI)
  • BRID 48.47
  • SKYE 52.82
  • Support Level
  • BRID $10.27
  • SKYE $2.70
  • Resistance Level
  • BRID $10.51
  • SKYE $3.29
  • Average True Range (ATR)
  • BRID 0.18
  • SKYE 0.45
  • MACD
  • BRID -0.03
  • SKYE 0.05
  • Stochastic Oscillator
  • BRID 48.89
  • SKYE 41.27

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are processing and distribution of frozen products, and processing and distribution of snack food products. It includes products such as biscuits, bread dough items, roll dough items, dry sausage products, and beef jerky. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. It derives a majority of its revenue from snack food products.

About SKYE Skye Bioscience Inc. Common Stock

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: